Mr Pietro D'Urso, Consultant Neurosurgeon
Mr Pietro D'Urso
Consultant Neurosurgeon
Mr Pietro D'Urso MD FRCS(SN)
Consultant Neurosurgeon
Mr Pietro D'Urso
Consultant Neurosurgeon MD FRCS(SN)
Areas of expertise
- Headaches
- Brain and spinal tumours
- Epilepsy
- Back pain, sciatica and neck pain
- Sacroiliac joint pain
Make an appointment
Address
-
HCA UK at The Wilmslow Hospital
52-54 Alderley Road Wilmslow, London, SK9 1NY
-
The Christie Private Care
Wilmslow Road, Manchester, M20 4BX
About Mr Pietro D'Urso
GMC number: 7150353
Year qualified: 2004
Place of primary qualification: Universita degli Studi di Bari
Mr Pietro Ivo d'Urso is a consultant neurosurgeon based in Manchester, where he has been practising since 2014. He qualified in 2009 from Italy, where he also completed his training.
Mr Ivo d'Urso routinely manages a wide range of general neurosurgical conditions, including brain tumours, degenerative spine issues, trauma, hydrocephalus, neck pain, and low back pain. His areas of expertise are extensive and include the surgical treatment of both benign and malignant brain tumours, awake craniotomies with brain mapping, fluorescence-guided resection of brain tumours, intraoperative neurophysiology monitoring, minimally invasive cranial surgery, and cranial endoscopy.
In his role, Mr Ivo d'Urso performs a variety of advanced medical procedures. These include awake craniotomy, intraoperative neurophysiology monitoring, brain mapping, and surgeries for low-grade and high-grade gliomas, meningiomas, pineal tumours, and brain metastasis. He is also skilled in minimally invasive cranial surgery, endoscopic cranial surgery, and surgery for Chiari malformation.
Mr Ivo d'Urso treats a range of conditions such as brain tumours, gliomas, meningiomas, sciatica, metastases, and pineal tumours. His commitment to patient care and his expertise in neurosurgery make him a highly respected specialist in his field.
Professional memberships
Articles by Mr Pietro D'Urso
Mir-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting gaba receptors